Esperante Ventures

Esperante Ventures is a Netherlands-based corporate venture capital firm specializing in investments in therapeutics and diagnostics companies during late preclinical or clinical development stages. The firm focuses on opportunities in Europe and North America, aiming to support the growth of innovative healthcare solutions.

Established in 2004, Esperante Ventures has built a diverse portfolio of companies across various countries, including the United States, United Kingdom, Netherlands, Israel, and France. Their investment strategy encompasses a range of stages, from pre-seed to Series C and beyond, with typical investments ranging from €100,000 to €2,000,000.

The firm's leadership brings decades of cross-functional management experience in the human healthcare industry, providing portfolio companies with extended management resources, particularly in business development. This expertise complements their financial contributions, aiming to accelerate the growth and success of their investee companies.